We are live on ! Find out more
BIOA

BioAmber Inc.
BIOA

Delisted

BIOA was delisted on the 8th of February, 2018.

Back to rankings

19 hedge funds and large institutions have $41.2M invested in BioAmber Inc. in 2013 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 2

51% more capital invested

Capital invested by funds: $27.3M → $41.2M (+$13.9M)

27% more funds holding

Funds holding: 15 → 19 (+4)

20% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 5

Holders
19
Holders Change
+4
Holders Change %
+26.67%
% of All Funds
0.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
4
Reduced
5
Closed
2
Calls
$1.08M
Puts
–
Net Calls
+$1.08M
Net Calls Change
+$294K

Top Buyers

Rank Fund Capital Flow
1
LCS
Levin Capital Strategies
New York
+$1.14M
2
PWAM
Park West Asset Management
California
+$882K
3
RA
Royce & Associates
New York
+$719K
4
BIT
BlackRock Institutional Trust
California
+$163K
5
VKH
Virtu KCG Holdings
New York
+$158K

Top Sellers

Rank Fund Capital Flow
1
CS
Credit Suisse
Switzerland
-$1.61M
2
PRCM
Pine River Capital Management
Minnesota
-$610K
3
Millennium Management
Millennium Management
New York
-$603K
4
SCM
Saba Capital Management
New York
-$196K
5
UOC
UBS O'Connor
Illinois
-$177K
Name Holding Trade Value Shares
Change 		Change in
Stake
WRF
1
Waddell & Reed Financial
Kansas
$22.6M – – –
ACPU
2
Arrowgrass Capital Partners (US)
Delaware
$5.65M – – –
PRCM
3
Pine River Capital Management
Minnesota
$5.62M -$610K -89,200 -11%
LCS
4
Levin Capital Strategies
New York
$2.56M +$1.14M +166,702 +95%
Alyeska Investment Group
5
Alyeska Investment Group
Illinois
$1.08M – – –
PWAM
6
Park West Asset Management
California
$964K +$882K +128,910 New
RA
7
Royce & Associates
New York
$785K +$719K +105,000 New
SCM
8
Saba Capital Management
New York
$740K -$196K -28,568 -22%
Deutsche Bank
9
Deutsche Bank
Germany
$337K +$684 +100 +0.2%
NIMI
10
Natixis Investment Managers International
France
$239K – – –
BIT
11
BlackRock Institutional Trust
California
$183K +$163K +23,856 +4,222%
VKH
12
Virtu KCG Holdings
New York
$173K +$158K +23,088 New
Goldman Sachs
13
Goldman Sachs
New York
$118K -$4.57K -667 -4%
CS
14
Credit Suisse
Switzerland
$92K -$1.61M -234,985 -95%
Morgan Stanley
15
Morgan Stanley
New York
$37K +$34.2K +5,000 New
TRCT
16
Tower Research Capital (TRC)
New York
$8K -$10.5K -1,538 -58%
Royal Bank of Canada
17
Royal Bank of Canada
Ontario, Canada
$4K +$3.42K +500 New
Barclays
18
Barclays
United Kingdom
$3K +$2.48K +362 +1,341%
Millennium Management
19
Millennium Management
New York
– -$603K -123,000 Closed
UOC
20
UBS O'Connor
Illinois
– -$177K -36,168 Closed
Bank of America
21
Bank of America
North Carolina
– +$233 +34 New

BIOA Hedge Fund Activity: Q4 2013 in Review

19 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in BioAmber Inc. (BIOA) for Q4 2013, worth a combined $41.2M — up 51% from $27.3M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new BIOA positions and 2 closed out — a net gain of 4 holders — while 4 added to existing stakes and 5 trimmed.

The largest buyer was Levin Capital Strategies, adding an estimated $1.14M. The largest seller was Credit Suisse, cutting an estimated $1.61M.

  • 19 institutional investors held BioAmber Inc. (BIOA) as of Q4 2013, up from 15 in Q3 2013.
  • Funds reported $41.2M of BioAmber Inc. stock for Q4 2013, up 51% quarter-over-quarter.
  • 6 funds opened new BioAmber Inc. positions in Q4 2013 and 2 closed out, a net change of +4 holders.
  • The largest BioAmber Inc. buyer in Q4 2013 was Levin Capital Strategies, an estimated $1.14M added.
  • The largest BioAmber Inc. seller in Q4 2013 was Credit Suisse, an estimated $1.61M sold.

Based on aggregated 13F filings for Q4 2013.